You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Han GH, Yun H, Kim H, et al
2022-RA-630-ESGO Overexpression of PDEA1 is a predictive biomarker for platinum resistance and poor prognosis in epithelial ovarian cancer by regulating cell cycle
International Journal of Gynecologic Cancer 2022;32:A246-A247.